Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joshua K. Sabari
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Relevance of Genetic Alterations in Squamous and Small Cell Lung Cancer
Annals of Translational Medicine
Medicine
Related publications
P2.03-14 PKCi-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant and Squamous Cell Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Atorvastatin Overcomes Gefitinib Resistance in KRAS Mutant Human Non-Small Cell Lung Carcinoma Cells
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer
Cancer Research
Cancer Research
Oncology
Activation of the Met Kinase Confers Acquired Drug Resistance in FGFR-targeted Lung Cancer Therapy
Oncogenesis
Cancer Research
Molecular Biology
KRAS Mutation, KRAS–LCS6 Polymorphism, and Non-Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
A Decade of Targeted Therapy for Non-Small Cell Lung Cancer
Influence of EGFR-activating Mutations on Sensitivity to Tyrosine Kinase Inhibitors in a KRAS Mutant Non-Small Cell Lung Cancer Cell Line
PLoS ONE
Multidisciplinary
Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
SY2-4Development of Targeted Therapy for Advanced Non-Small Cell Lung Cancer With Rare Driver Oncogenes as RET or MET
Annals of Oncology
Medicine
Oncology
Hematology